SGPNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
SpyGlass Pharma, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$24.60+0.60 (+2.50%)
Close on Oct 19, 2026
- Market cap
- $822.61M
- P/E (TTM)
- –
- Dividend yield
- –